Arcadia Biosciences Stock Today
| RKDA Stock | USD 3.30 0.14 4.07% |
PerformanceVery Weak
| Odds Of DistressHigh
|
Arcadia Biosciences is trading at 3.30 as of the 20th of March 2025, a 4.07 percent decrease since the beginning of the trading day. The stock's open price was 3.44. Arcadia Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Food, Beverage & Tobacco | IPO Date 15th of May 2015 | Category Consumer Defensive | Classification Consumer Staples |
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company was incorporated in 2002 and is headquartered in Davis, California. Arcadia Bio operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. The company has 1.36 M outstanding shares of which 14.96 K shares are at this time shorted by private and institutional investors with about 2.12 trading days to cover. More on Arcadia Biosciences
Moving together with Arcadia Stock
| 0.66 | VITL | Vital Farms Sell-off Trend | PairCorr |
Moving against Arcadia Stock
Arcadia Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Stanley Jacot | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Agricultural Products & Services, Food, Beverage & Tobacco, Consumer Defensive, Natural Foods, Agriculture, Consumer Staples, Food Products, Agricultural Inputs, Basic Materials (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsArcadia Biosciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Arcadia Biosciences' financial leverage. It provides some insight into what part of Arcadia Biosciences' total assets is financed by creditors.
| |||||
Arcadia Biosciences (RKDA) is traded on NASDAQ Exchange in USA. It is located in 5950 Sherry Lane, Dallas, TX, United States, 75225 and employs 21 people. Arcadia Biosciences is listed under Agricultural Products & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.69 M. Arcadia Biosciences conducts business under Food Products sector and is part of Consumer Staples industry. The entity has 1.36 M outstanding shares of which 14.96 K shares are at this time shorted by private and institutional investors with about 2.12 trading days to cover.
Arcadia Biosciences currently holds about 21.23 M in cash with (15.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check Arcadia Biosciences Probability Of Bankruptcy
Ownership AllocationAlmost 88.44 percent of Arcadia Biosciences outstanding shares are held by general public with 0.82 (percent) owned by insiders and only 10.74 % by other corporate entities.
Check Arcadia Ownership Details
Arcadia Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Genworth Financial Wealth Mgmt Inc | 2024-12-31 | 5.0 | |
| Oliver Lagore Vanvalin Investment Group | 2024-09-30 | 4.0 | |
| Harbour Investments, Inc. | 2024-12-31 | 1.0 | |
| Tower Research Capital Llc | 2024-12-31 | 0.0 | |
| Northern Trust Investments N A | 2024-12-31 | 0.0 | |
| U.s. Bancorp | 2024-12-31 | 0.0 | |
| Mariner Wealth Advisors Llc | 2024-12-31 | 25 K | |
| Vanguard Group Inc | 2024-12-31 | 14 K | |
| Ubs Group Ag | 2024-12-31 | 13.9 K | |
| Geode Capital Management, Llc | 2024-12-31 | 12.3 K | |
| State Street Corp | 2024-12-31 | 12.1 K |
Arcadia Biosciences Historical Income Statement
Arcadia Stock Against Markets
Arcadia Biosciences Corporate Management
| Belinda Yao | VP Operations | Profile | |
| Brian Schaffer | Senior Sales | Profile | |
| Kevin Hodges | VP Operations | Profile | |
| Mark Kawakami | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Earnings Share (6.77) | Revenue Per Share | Quarterly Revenue Growth 0.184 | Return On Assets |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.